Recombinant PSMA Protein, Human (His Tag) Recombinant Proteins The human FOLH1 (NP_004467.1) (Lys44-Ala750) was expressed with a polyhistidine tag at the N-terminus. The purified protein was biotinylated in vitro The recombinant human FOLH1 consists of 715a.a and predicts a molecular weight of 80.5 kDa.
$ $99 In stock
Formulation: The recombinant human FOLH1 consists of 715a.a and predicts a molecular weight of 80.5 kDa.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant PSMA Protein, Human (His Tag)

Formulation: Recombinant PSMA Protein was lyophilized from sterile PBS, pH 7.4.1

Source: HEK293 Cells

Product Name Recombinant PSMA Protein, Human (His Tag)
Product Type Recombinant Protein
Source HEK293 Cells
Formulation Recombinant PSMA Protein was lyophilized from sterile PBS, pH 7.4.1
Molecular Weight The recombinant human FOLH1 consists of 715a.a and predicts a molecular weight of 80.5 kDa.
Endotoxin < 1.0 EU per μg protein as determined by the LAL method
Purity Greater than 90% as determined by SDS-PAGE.
Description The human FOLH1 (NP_004467.1) (Lys44-Ala750) was expressed with a polyhistidine tag at the N-terminus. The purified protein was biotinylated in vitro
Host Species Homo sapiens (Human)
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Lys44-Ala750
Product Background Glutamate carboxypeptidase 2, also known as Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, Prostate-specific membrane antigen, GCPII, PSMA, FOLH1, and NAALAD1, is a single-pass type II membrane protein which belongs to thepeptidase M28 family and M28B subfamily. FOLH1 is highly expressed in prostate epithelium. It is detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon, brain (at protein level), and the capillary endothelium of a variety of tumors. FOLH1 has both folate hydrolase and N-acetylated alpha linked acidic dipeptidase (NAALADase) activity. It has a preference for tri-alpha-glutamate peptides. Genetic variation in FOLH1 may be associated with low folate levels and consequent hyperhomocysteinemia. This condition can result in increased risk of cardiovascular disease, neural tube defects, and cognitive deficits. FOLH1 also shows a promising role in directed imaging and therapy of recurrent or metastatic disease.Immune CheckpointImmunotherapyCancer ImmunotherapyTargeted Therapy
Memo FGCP Protein, Human;FOLH Protein, Human;GCP2 Protein, Human;GCPII Protein, Human;mGCP Protein, Human;NAALAD1 Protein, Human;NAALAdase Protein, Human;PSM Protein, Human;PSMA Protein, Human
Terminal His
Bioactivity Please contact us for detailed information